Why Is Aducanumab Priced at $56,000 per Patient? Lessons for Drug-Pricing Reform

Why Is Aducanumab Priced at $56,000 per Patient? Aducanumab's price can inform the drug-pricing policy debate because it responds to key features of the market environment for physician-administered drugs: Medicare's reimbursement formula, payment to physicians for infused drugs, and cost-sharing requirements.

Automated summary

The price of Aducanumab responds to key features of the physician-administered drug market environment, providing valuable information for the drug pricing policy debate.